Endometrial ablation using a distensible multielectrode balloon

Soderstrom, Richard M.; Brooks, Philip G.; Corson, Stephen L.; Dequesne, J.; Gallinat, A; Garza-Leal, J.; Iglesias-Benavides, Jose Luis; Indman, Paul D.; Liu, James H.; Pas, H. Van Der; Stern, Roger A.; Sutton, Christopher; Vancaillie, Thierry G.; Wamsteker, Kees

doi:10.1016/s1074-3804(96)80071-5

Cited by 17 publications

(8 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Amso et al 10 reported an improvement in 88%‐91% of patients with the Thermachoice system, with an amenorrhoea rate of 15%. Soderstrom et al 15 observed an amenorrhoea rate of 40% and hypomenor‐rhoea rate of 49% with a shorter follow up period (less than 12 months) using the VesataBlate system.…”

Section: Discussionmentioning

confidence: 99%

Cavaterm thermal balloon ablation for the treatment of menorrhagia

Hawe¹,

Phillips²,

Chien

et al. 1999

BJOG

View full text Add to dashboard Cite

Fifty patients due to undergo endometrial ablation as a treatment of dysfunctional uterine bleeding were recruited to assess the efficacy and safety of a new thermal balloon ablation system (Cavaterm). The patients were followed up for a mean of 14 months (range 6-24): 34 (68%) have complete amenorrhoea, 12 (24%) only have spotting, two (4%) are eumenorrhoeic, and two (4%) have had failed treatments. There were no major complications, but two patients have required oral antibiotics for suspected endometritis. Although these preliminary results are encouraging, all patients remain under review to determine long term effect of the procedure. Further evaluation is also underway in the form of a randomised trial against endometrial laser ablation.

show abstract

Section: Discussionmentioning

confidence: 99%

Cavaterm thermal balloon ablation for the treatment of menorrhagia

Hawe¹,

Phillips²,

Chien

et al. 1999

BJOG

View full text Add to dashboard Cite

show abstract

“…Previous reports on the outcome of different balloon techniques have presented results for either a small number of patients or short follow‐up periods. 2–5 Since this is a new technique there is a need for continuous follow up. In the present study, the aim was to report details of the clinical outcome of the treatment of 117 patients followed for up to 4 years.…”

Section: Introductionmentioning

confidence: 99%

Thermal balloon endometrial destruction: the outcome of treatment of 117 women followed up for a maximum period of 4 years

Friberg

Åhlgren

2000

Gynaecol Endoscopy

View full text Add to dashboard Cite

Objective To study the long‐term results of treatment for menorrhagia involving the thermal destruction of the endometrium by means of a balloon catheter. Design Between August 1993 and December 1996, 117 women were treated and, in a prospective study, 116 (99%) of them were followed up with consultations and questionnaires. No pretreatment with gonadotrophin‐releasing hormone (GnRH) analogues was given. Setting Gynaecology department at a university hospital. Results There were no immediate peroperative complications. The success rate after 25 months (range 10–49) was 94%, excluding women with preoperative intracavitary changes and pretreatment ultrasonographically identified submucosal leiomyomas. Life‐table analysis showed that the probability of assessing the treatment as ‘excellent’ or ‘good’ and avoiding hysterectomy over a 49‐month period was 81%, and the probability of avoiding hysterectomy over the same time period was 85% when no exclusions were made. Conclusions For women with menorrhagia, who have no further wish for pregnancy, this study shows that thermal endometrial destruction by means of the balloon catheter technique is a safe type of day case procedure with a high success rate. Pretreatment examination is important in order to select women well suited for the treatment. A successful result 1 year after treatment implies a successful result in the long term.

show abstract

“…A disposable handset for the introduction of an electrode carrier, is connected by a cable to the generator. There is also a controller which monitors and distributes the electrical energy 2 …”

Section: Methodsmentioning

confidence: 99%

Endometrial ablation using a distensible multielectrode balloon: a long‐term follow‐up report

Jones

Spangler²,

Sutton

2002

Gynaecol Endoscopy

Self Cite

View full text Add to dashboard Cite

Objective To present long term follow up data on patients treated at The Royal Surrey County Hospital, who took part in an evaluation study of the Vesta™ system. Study design A prospective follow‐up study at 3.5–5 years following treatment. Subjects and methods Twenty‐five patients were asked to complete a questionnaire detailing their medical history since the initial Vesta™ system procedure, together with a validated pictorial blood loss assessment chart. A life table analysis of the patients enrolled into the European study was also carried out at 2 years. Results Of the 25 patients, a TCRE had to be carried out as a second operation in two patients because of continuing menorrhagia, and one patient had a pictorial blood loss score of >150 but did not want further treatment at 5 years. Therefore, treatment with the Vesta™ system failed to relieve the original symptoms or avoid second surgery in 3/25 (12%) of the patients in the long term. Life table analysis of the patients enrolled into the European study has demonstrated a failure rate of 11% at 2 years. Conclusion Our long term results suggest that the efficacy of the Vesta™ System at 2 years persists at 3.5–5 years following treatment.

show abstract

Endometrial ablation using a distensible multielectrode balloon

Cited by 17 publications

References 2 publications

Cavaterm thermal balloon ablation for the treatment of menorrhagia

Cavaterm thermal balloon ablation for the treatment of menorrhagia

Thermal balloon endometrial destruction: the outcome of treatment of 117 women followed up for a maximum period of 4 years

Endometrial ablation using a distensible multielectrode balloon: a long‐term follow‐up report

Contact Info

Product

Resources

About